NCT00502346 is a Phase 1 clinical trial of PM10 in Healthy, sponsored by Prism Pharmaceuticals.

Who is sponsoring NCT00502346?

NCT00502346 is sponsored by Prism Pharmaceuticals.

What drugs are being tested in NCT00502346?

Interventions in NCT00502346: PM10.

Is NCT00502346 still recruiting?

NCT00502346 is currently completed. Last updated 8 September 2017.

Last reviewed 2017-09-08 · How we verify

NCT00502346

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Trial to Determine the Relative Effect of PM101 I.V. Versus Placebo on Hemodynamics in Healthy Adult Volunteers

Completed Phase 1 Last updated 8 September 2017

What this trial tests

Phase 1 trial testing PM10 in Healthy in 342 participants. Completed in 2 November 2007.

Timeline

3 July 2007

Primary endpoint
2 November 2007

2 November 2007

Quick facts

Lead sponsor	Prism Pharmaceuticals
Phase	Phase 1
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Enrollment	342
Start date	3 July 2007
Primary completion	2 November 2007
Estimated completion	2 November 2007
Sites	1 location across Canada

Drugs / interventions tested

PM10 — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Prism Pharmaceuticals — full company profile →

Who can join

Adults 18 to 55, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The primary objective of the study is to compare the effect of PM101 I.V. administered as an immediate intravenous bolus versus placebo on systolic blood pressure. Secondary objectives include evaluation of change from baseline in heart rate and change from baseline to the lowest value in mean arterial pressure and diastolic pressure.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Other Prism Pharmaceuticals trials

Trials by the same sponsor.

NCT00420953 — Relative Bioavailability of PM101 IV and Cordarone IV · Phase 1 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00502346 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Prism Pharmaceuticals
Last refreshed: 8 September 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00502346.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing